Disc Medicine, Inc. Notes Reduction
Disc Medicine, Inc. (IRON) reported Notes Reduction of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesReduction · last filed 2022-03-10
- Disc Medicine, Inc. notes reduction for the quarter ending 2020-12-31 was $0.00.
- Disc Medicine, Inc. notes reduction for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- Disc Medicine, Inc. notes reduction for fiscal 2020 was $8.18M.
| Period end | Notes Reduction 3 month | Notes Reduction 9 month | Notes Reduction 12 month |
|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-10 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $8.18M 10-K · filed 2022-03-10 | |
| 2020-09-30 | $8.18M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |